α—糜蛋白酶等鞘内注射治疗结核性脑膜炎临床体会

• 作 者: 王丽丽 刘武晶 潘淑云 马丽
• 机 构: 牡丹江医学院附属三院儿内科,牡丹江医学院附属三院儿内科,牡市矿山机械厂职工医院,牡市结核医院
• 出 处: 牡丹江医学院学报
• 发表日期: 1994年01期
• 关键词: 结核性脑膜炎 糜蛋白酶 鞘内注射治疗 室管膜炎 雷米封 结脑 临床症状 室间孔 核性 脑动脉炎

结核性脑膜炎是小儿一种严重的病症之一.如诊断不及时或治疗不当,病死率和后遗症的发生率仍然较高.我们对1989年—1992年底的50例结核性脑膜炎实措鞘内注射疗法(有对照组),其结果表明:对结核性脑膜炎用α—糜蛋白酶等药物进行鞘内注射,可迅速改善临床症状,减少后遗症的发生率,促进结核性脑膜炎早期恢复,降低病死率.

Tuberculous meningitis is a serious condition in children, such as the diagnosis is not timely or improper treatment, the incidence of mortality and sequelae is still high. We from 1989 to 1992 at the end of 50 cases of tuberculous meningitis really sheath Intrathecal injection (control group), the results showed that: the tuberculous meningitis with α-chymotrypsin drugs such as intrathecal injection can rapidly improve clinical symptoms, reduce the incidence of sequelae, and promote the early recovery of tuberculous meningitis, Reduce mortality.